Interference of sub-inhibitory concentrations of gatifloxacin on various determinants of bacterial virulence

Journal of Chemotherapy

Volumn 14, Issue 5, 2002, Pages 473-482

  Dal Sasso, M ^a   Bovio, C ^a   Culici, M ^a   Braga, P C ^a  

^a Centro di Farmacologia Respiratoria   (Italy)

Author keywords

Adhesiveness; Bacterial virulence; Gatifloxacin; Hemagglutination; Hydrophobicity; Killing; Phagocytosis; Respiratory bursts

Indexed keywords

GATIFLOXACIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; ESCHERICHIA COLI; HEMAGGLUTINATION TEST; HUMAN; HUMAN CELL; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PHARMACODYNAMICS; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

EID: 0036810493     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.5.473     Document Type: Article

References (35)

1. Ahlstedt S. The antibacterial effects of low concentrations of antibiotics and host defence factors: A review. J Antimicrob Agents 1981; 8 (Suppl C) 59-70.
2. Relman DA, Falkow S. A molecular perspective of microbial pathogenicity. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infections Diseases. Churchill Livingstone, New York, 1995; 19-29.
3. Braga PC, Dal Sasso M, Sala MT. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence. J Antimicrob Chemother 2000; 45:15-25.
4. Chopra I, Linton A. The antibacterial effects of low concentrations of antibiotics. Adv Microb Physiol 1986; 28: 212-259.
5. Braga PC, Dal Sasso M, Maci S, Reggio S, Piatti G. Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of Escherichia coli. Chemotherapy 1995; 41: 50-58.
6. Odenholt-Tornqvist IO, Löwdin E, Cars O. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob Agents Chemother 1991; 35: 1834-1839.
7. Mandell LA, Afuan M. Mechanisms of interaction among subinhibitory concentrations of antibiotics, human polymorphonuclear neutrophils and gram-negative bacilli. Antimicrob Agents Chemother 1991; 35: 1291-1297.
8. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobicallly: Approved Standard M7-A2. NCCLS, Villanova, PA, 1990.
9. Ellen RP, Gibbons RS. M-protein associated adherence of Streptococcus pyogenes to epithelial surfaces: Prerequisite for virulence. Infect & Immun 1972; 5: 826-830.
10. Lorian V. Antibiotics in Laboratory Medicine. Baltimore: William Wilkins, 1986: 77-78.
11. Herbert RA. Methods for enumerating microorganosms and determining biomass in natural environments. Meth Microbiol 1990; 22: 1-85.
12. Ljungh A, Wadström T. Salt aggregation test for measuring cell surface hydrophobicity of urinary Escherichia coli. Eur J Clin Microbiol 1982; 1: 388-393.
13. Lanyi JK. Salt-dependent properties of proteins from extremely halophilic bacteria. Bacteriol Rev 1974; 38: 272-290.
14. Rozgonyi F, Szitha KR, Hjerten S, Wadström T. Standardization of salt aggregation test for reproducible determination of cell-surface hydrophobicity with special reference to Staphylococcus species. J Appl Bacteriol 1985; 59: 451-457.
15. Gilles RR, Duguid JP. The fimbrial antigens of Shigella flexneri. J Hyg 1958; 56: 303-318.
16. Korhonen TK. Yeast cell agglutination by purified enterobacteriaceae pili. FEMS Microbiol Lett 1979; 6: 421-425.
17. Bellinati-Pires R, Melki SE, Colletto GMDD, Carneiro-Sampaio MMS. Evaluation of a fluorochrome assay for assessing the bactericidal activity of neutrophils in human phagocyte dysfunctions. J Immunol Meth 1989;119:189-196.
18. Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiol Lett 1977; 1: 357-361.
19. Goldner M, Farkas-Hirnsley H, Kormendy A, Skinner M. Bacterial phagocytosis monitored by fluorescence and extracellular quenching: Ingestion and intracellular killing. Lab Med 1983;14: 291-294.
20. Robinson P, Wakefield D, Breist SN, Easter JF, Penny R. Chemiluminescence response to pathogenic organisms: Normal human polymorphonuclear leukocytes. Infect Immun 1984; 43: 744-752.
21. Nakashima M, Uematsu T, Kosuge T, et al. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother 1995; 39: 2635-2640.
22. Milatovic D. Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus. Eur J Clin Microbiol 1982; 1: 97-101.
23. Braga PC, Sala MT, Dal Sasso M. Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors. Antimicrob Agents Chemother 1999; 43: 1013- 1019.
24. Burnham JC, Sostein SA. Anti-virulence effects of lomefloxacin and other quinolones (Abstr.) In: Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 1990.
25. Desnottes JF, Le Roy D, Diallo N. Effect of subminimal inhibitory concentrations of pefloxacin on the piliation and adherence of E. coli. Drugs Exp Clin Res 1988; 14: 629-634.
26. Burnham JC. Mediation by enoxacin of adherence of Escherichia coli to uroepithelial cells. Rev Infect Dis 1988; 10 (Suppl):S175-S179.
27. Duncker D, Ullmann U. Influence of various antimicrobial agents on the chemiluminescence of phagocytosing human granulocytes. Chemotherapy 1986;32:18-24.
28. Kubo S, Matsumoto T, Takahashi K et al. Enhanced chemiluminescence response of polymorphonuclear leukocytes by new quinolone antimicrobials. Chemotherapy 1994; 40: 333-336.
29. Rubinstein E, Shalit I. Effects of the quinolones on the immune system. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents (2nd Ed.) Washington DC: American Society for Microbiology, 1993: 519-526.
30. Forsgren A, Bergwvist PI, Effect of cyprofloxacin on phagocytosis. Eur J Clin Microbiol 1985; 4: 575-578.
31. Pulverer G, Peters G. Investigations on ofloxacin: Antibacterial activity and influence on the immune system. Infection 1986;14 (Suppl. 4): 247-247.
32. Sonstein SA, Burnham JC. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms. Diagn Microbiol Infect Dis 1993; 16: 277-289.
33. Pruul H, McDonald PJ. Lomefloxacin induced modification of the kinetics of growth of Gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils. J Antimicrob Chemother 1990; 25: 91-101.
34. Peman J, Canton E, Hernandez MT, Gobernado N. Intraphagocytic killing of Gram-positive bacteria by ciprofloxacin. J Antimicrob Chemother 1994; 34: 965-974.
35. Yamamoto T, Kusajima H, Hosaka M, et al. Uptake and intracellular activity of AM-1155 in phagocytic cells. Antimicrob Agents Chemother 1996; 40: 2756-2759.